510(k) K232688— NQ TMS for MDD (NQv1-MU-01)

Substantially Equivalent

Neuroqore, Inc.

Clearance details

Applicant: Neuroqore, Inc.
Product code: Code OBP
Advisory panel: Neurology
Date received: 2023-09-01
Decision date: 2023-12-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Francisco, CA, US

Adverse events under product code OBP

product code OBP

Injury: 270
Total: 270

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.